Vibrio cholerae O139 Bengal - 10 Years on

Reviews and Research in Medical Microbiology

Volumn 16, Issue 4, 2005, Pages 135-143

  Albert, M John ^a   Nair, G Balakrish ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Antimicrobial resistance; Cholera; Eighth pandemic; Environmental variable; Epidemic; Inflammatory response; Molecular typing; Phages; Vibrio cholerae O139 Bengal

Indexed keywords

COTRIMOXAZOLE; TETRACYCLINE; UNCLASSIFIED DRUG; VACCINE; VIBRIO CHOLERAE VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIOPHAGE; BACTERIOPHAGE TYPING; BACTERIUM ISOLATE; CELL CLONING; CHOLERA; DIARRHEA; ENVIRONMENTAL FACTOR; EPIDEMIC; GENE TRANSFER; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LYSOGENIZATION; MOLECULAR TYPING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEASONAL VARIATION; SERODIAGNOSIS; SEROLOGY; VIBRIO CHOLERAE;

EID: 26044474222     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.revmedmi.0000184743.75679.0a     Document Type: Review

References (96)

1. Ramamurthy T, Garg S, Sharma R, Bhattacharya SK, Nair GB, Shimada T, et al. Emergence of a novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 1993; 341:703-704.
2. Albert MJ, Siddique AK, Islam MS, Faruque ASG, Ansaruzzaman M, Faruque SM, et al. A large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet 1993; 341:704.
3. Shimada T, Nair GB, Deb BC, Albert MJ, Sack RB, Takeda Y. Outbreak of Vibrio cholerae non-O1 in India and Bangladesh. Lancet 1993; 341:1347.
4. Albert MJ. Vibrio cholerae O139 Bengal. J Clin Microbiol 1994; 32:2345-2349.
5. Johnson JA, Salles CA, Panigrahi P, Albert MJ, Wright AC, Johnson RJ, et al. Vibrio cholerae O139 synonym Bengal is closely related to Vibrio cholerae O1 El Tor, but has important differences. Infect Immun 1994; 62:2108-2110.
6. Meno Y, Waldor MK, Mekalanos JJ, Amako K. Morhological and physical characterization of the capsule layer of Vibrio cholerae O139. Arch Microbiol 1998; 170:339-344.
7. Albert MJ, Qadri F, Bhuiyan NA, Ahmad SM, Ansaruzzaman M, Weintraub A. Phagocytosis of Vibrio cholerae O139 Bengal by human polymorphonuclear leukocytes. Clin Diagn Lab Immunol 1999; 6:276-278.
8. Manning PA, Stroeher UH, Morona R. Molecular basis for O-antigenic biosynthesis in Vibrio cholerae O1: Ogawa-Inaba switching. In: Wacksmuth IK, Blake PA, Olsvik O, editors. Vibrio cholerae and Cholera: Molecular To Global Perspectives. Washington, D.C.: American Society for Microbiology; 1994:77-94.
9. Weintraub A, Widmalm G, Jansson PE, Jansson M, Hultenby K, Albert MJ. Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence. Microb Pathog 1994; 16:235-241.
10. Hisatsune K, Kondo S, Isshiki Y, Iguchi T, Kawamata Y, Shimada T. O antigenic lipopolysaccharide of Vibrio cholerae O139 Bengal, a new epidemic strain for recent cholera in the Indian subcontinent. Biochem Biophys Res Commun 1993; 196:1309-1315.
11. Cox AD, Perry MB. Structural analysis of the O-antigen-core region of the lipopolysaccharide from Vibrio cholerae O139. Carbohdrate Res 1996; 290:59-65.
12. Shimada T, Arakawa E, Itoh K, Nakazato T, Okitsu T, Yamai S, et al. Two strains of Vibrio cholerae non-O1 possessing somatic (O) antigen factors in common with Vibrio cholerae serogroup O139 synonym Bengal. Curr Microbiol 1994; 29:331-333.
13. Bik EM, Bunschoten AE, Gouw RD, Mooi FR. Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J 1995; 14:209-216.
14. Comstock LE, Johnson JA, Michalski JM, Morris JG Jr, Kaper JB. Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol 1996; 19:815-826.
15. Stroeher UH, Manning PA. Vibrio cholerae serotype O139: swapping genes for surface polysaccharide biosynthesis. Trends Microbiol 1997; 5:178-180.
16. Dumontier S, Berche P. Vibrio cholerae O22 might be a putative source of exogenous DNA resulting in the emergence of the new strain of Vibrio cholerae O139. FEMS Microbiol Lett 1998; 164:91-98.
17. Yamasaki S, Garg S, Nair GB, Takeda T. Distribution of Vibrio cholerae O1 antigen biosynthesis genes among O139 and other non-O1 serogroups of Vibrio cholerae. FEMS Microbiol Lett 1999; 179:115-121.
18. Faruque SM, Saha MN, Asadulghani, Sack DA, Sack RB, Takeda Y, et al. The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors. J Infect Dis 2000, 182:1161-1168.
19. Garg P, Aydanian A, Smith D, J Glenn M, Nair GB Jr, Stine OC. Molecular epidemiology of O139 Vibrio cholerae: mutation, lateral gene transfer, and founder flush. Emerg Infect Dis 2003; 9:810-814.
20. Faruque SM, Saha MN, Asadulghani, Bag PK, Bhadra RK, Bhattacharya SK, et al. Genomic diversity among Vibrio cholerae O139 strains isolated in Bangladesh and India between 1992 and 1998. FEMS Microbiol Lett 2000, 184:279-284.
21. Basu A, Garg P, Datta S, Chakraborty S, Bhattacharya T, Khan A, et al. Vibrio cholerae O139 in Calcutta, 1992-1998: incidence, antibiograms, and genotypes. Emerg Infect Dis 2000; 6:139-147.
22. ICDDR,B Cholera Working Group. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 1993, 342:387-390.
23. Bhattacharya SK, Bhattacharya MK, Nair GB, Dutta D, Deb A, Garg S, et al. Clinical profile of acute diarrhoea cases infected with the new epidemic strain of Vibrio cholerae O139: designation of the disease as cholera. J Infect 1993; 27:11-15.
24. Faruque ASG, Mahalanabis D, Hoque SS, Albert MJ. The relationship between ABO blood groups and susceptibility to diarrhea due to Vibrio cholerae O139. Clin Infect Dis 1994; 18:827-828.
25. Faruque AS, Mahalanabis D, Albert MJ, Hoque SS. Studies of infection with Vibrio cholerae O139 synonym Bengal in family contacts of index cases. Trans R Soc Trop Med Hyg 1994; 88:439.
26. Sengupta PG, Sircar BK, Mandal SK, Mukhopadhyay AK, Nair GB, Gupta DN, et al. Epidemiology of Vibrio cholerae O139 with special reference to intrafamilial transmission in Calcutta. J Infect 1995; 31:45-47.
27. Hossain MS, Salam MA, Rabbani GH, Biswas R, Mahalanabis D. Vibrio cholerae O139 Bengal: a descriptive study. J Health Popul Nutr 2000; 18:27-32.
28. Hossain MS, Salam MA, Rabbani GH, Kabir I, Biswas R, Mahalanabis D. Tetracycline in the treatment of severe cholera due to Vibrio cholerae O139 Bengal. J Health Popul Nutr 2002; 20:18-25.
29. Silva TM, Schleupner MA, Tacket CO, Steiner TS, Kaper JB, Edelman R, et al. New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and O139 Vibrio cholerae. Infect Immun 1996; 64:2362-2364.
30. Qadri F, Raqib R, Ahmed F, Rahman T, Wenneras C, Das SK, et al. Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin Diagn Lab Immunol 2002; 9:221-229.
31. Qadri F, Bhuiyan TR, Dutta KK, Raqib R, Alam MS, Alam NH, et al. Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induces increases in innate cells and inflammatory mediators at the mucosal surface of the gut. Cut 2005; 53:62-69.
32. Glass RI, Svennerhplm A-M, Khan MK, Huda S, Huq MI, Holmgren J. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J Infect Dis 1985; 151:236-242.
33. Morris JG Jr, Losonsky GE, Johnson JA, Tacket CO, Nataro JP, Panigrahi P, et al. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J Infect Dis 1995; 171:903-908.
34. Qadri F, Mohi G, Hossain J, Azim T, Khan AM, Salam MA, et al. Comparison of vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin Diagn Lab Immunol 1995; 2:685-688.
35. Attridge SR, Qadri F, Albert MJ, Manning PA. Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement mediated bacteriolysis. Clin Diagn Lab Immunol 2000; 7:444-450.
36. Attridge SR, Johansson C, Trach DD, Qadri F, Svennerholm A-M. Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139. Clin Diagn Lab Immunol 2002; 9:383-387.
37. Losonsky GA, Lim Y, Motamedi P, Comstock L, Johnson JA, Morris JG Jr et al. Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity. Clin Diagn Lab Immunol 1997; 4:264-269.
38. Saha D, LaRocque RC, Khan Al, Harris JB, Begum YA, Akramuzzaman SM, et al. Incomplete correlation of serum vibriocidal antibody titer with protection with Vibrio cholerae infection in urban Bangladesh. J Infect Dis 2004; 189:2318-2322.
39. Qadri F, Wenneras C, Albert MJ, Hossain J, Mannoor K, Begum YA, et al. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect Immun 1997, 65:3571-3576.
40. Qadri F, Jonson G, Begum YA, Wenneras C, Albert MJ, Saloam MA, et al. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O139. Clin Diagn Lab Immunol 1997; 4:429-434.
41. Attridge SR, Wallerstrom G, Qadri F, Svennerholm A-M. Detection of antibodies to toxin-coregulated pili in sera from cholera patients. Infect Immun 2004; 72:1824-1827.
42. Karaolis DK, Somara S, Maneval DR Jr, Johnson JA, Kaper JB. A bacteriophage encoding a pathogenicity island, a type -IV pilus and a phage receptor in cholera bacteria. Nature 1999; 399:375-379.
43. Kimsey HH, Nair GB, Ghosh A, Waldor MK. Diverse CTXφ and evolution of new pathogenic Vibrio cholerae. Lancet 1998; 352:457-458.
44. Davis BM, Kimsey HH, Chang W, Waldor MK. The Vibrio cholerae O139 Calcutta bacteriophage CTXφ is infectious and encodes a novel repressor. J Bacteriol 1999; 181:6779-6787.
45. Nusrin S, Khan GY, Bhuiyan NA, Ansaruzzaman M, Hossain MA, Safa A, et al. Diverse CTX phages among toxigenic Vibrio cholerae O1 and O139 strains isolated between 1994 and 2002 in an area where cholera is endemic in Bangladesh. J Clin Microbiol 2004; 42:5854-5856.
46. Davis BM, Kimsey HH, Kane AV, Waldor MK. A satellite phage-encoded antirepressor induces repressor aggregation and cholera toxin gene transfer. EMBO J 2002; 21:4240-4249.
47. Rubin E, Waldor MK, Mekalanos JJ. Mobile genetic elements and the evolution of new epidemic strains of Vibrio cholerae. In: Emerging Infections: Biomedical Research Reports. Edited by Krause RM. New York: Academic Press; 1998: 147-161.
48. Ehara M, Shimodori S, Kojima F, Ichinose Y, Hirayama T, Albert MJ, et al. Characterization of filamentous phages of Vibrio cholerae O139 and O1. FEMS Microbiol Lett 1997; 154:293-301.
49. Ikema K, Honma Y. A novel filamentous phage, fs-2, of Vibrio cholerae O139. Microbiology 1998; 144:1901-1906.
50. Reidl KM, Mekalanos JJ. Characterization of Vibrio cholerae bacteriophages K139 and use of a novel mini-transposon to identify a phage-encoded virulence factor. Mol Microbiol 1995; 18:685-701.
51. Smironova NI, Chekhovskaya GV, Davidova NI, Livanova LF, Yeroshenko GA. Virulence-associated characterization and phage lysogenicity of two morphologically distinct colonies of Vibrio cholerae O139 serogroup. FEMS Microbiol Lett 1996; 136:175-180.
52. Jouravleva EA, McDonald GA, Garon GF, Boesman-Finkelstein M, Finkelstein RA. Characterisation and possible functions of a new filamentous bacteriophage from Vibrio cholerae O139. Microbiology 1998; 2:315-324.
53. Jouravleva EA, McDonald GA, Marsh JW, Taylor RK, Boesman-Finkelstein M, Finkelstein RA. The Vibrio cholerae mannose-sensitive hemagglutinin is the recptor for a filamentous bacteriophage from V. cholerae O139. Infect Immun 1998; 66: 2535-2539.
54. Albert MJ, Bhuiyan NA, Rahman A, Ghosh AN, Hultenby K, Weintraub A, et al. Phage specific for Vibrio cholerae O139 Bengal. J Clin Microbiol 1996; 34:1843-1845.
55. Chakrabarti AK, Ghosh AN, Nair GB, Niyogi SK, Bhattacharya SK, Sarkar BL. Development and evaluation of a phage typing scheme for Vibrio cholerae O139. J Clin Microbiol 2000; 38:44-49.
56. Faruque SM, Islam MJ, Ahmad QS, Faruque ASG, Sack DA, Nair GB, et al. Self-limiting nature of seasonal cholera epidemics: role of host-mediated amplification of phage. Proc Natl Acad Sci USA 2005; 102:6119-6124.
57. Faruque SM, Naser IB, Islam MJ, Faruque ASG, Ghosh AN, Nair GB, et al. Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc Natl Acad Sci USA 2005; 102:1702-1707.
58. Huq A, Sack RB, Nizam A, Longini IM, Nair GB, Ali A, et al. Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh. Appl Environ Microbiol 2005; 71:4645-4654.
59. Rivas M, Toma C, Miliwebsky E, Caffer MI, Galas M, Varela P, et al. Cholera isolates in relation to the "eighth pandemic". Lancet 1993, ii:926-927.
60. Parveen S, Farrah SR, Gonzalez-Bonilla C, Zamudio AV, Tamplin ML. Characterization of a clinical Vibrio cholerae O139 isolate from Mexico. Can J Microbiol 2003; 49:65-70.
61. Albert MJ, Islam D, Nahar S, Qadri F, Falklind S, Weintraub A. Rapid detection of Vibrio cholerae O139 Bengal from stool specimens by PCR. J Clin Microbiol 1997; 35:1633-1635.
62. Hoshino K, Yamasaki S, Mukhopadhyay AK, Chakraborty S, Basu A, Bhattacharya SK, et al. Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol Microbiol 1998; 20:201-207.
63. Qadri F, Chowdhury A, Hoddsin J, Chowdhury K, Azim T, Shimada T, et al. Development and evaluation of rapid monoclonal antibody based coagglutination test for direct detection of Vibrio cholerae O139 synonym Bengal in stool samples. J Clin Microbiol 1994; 32:1589-1590.
64. Chaicumpa W, Srimanote P, Sakolvaree Y, Kalampaheti T, Chongsa-nguan M, Tapchaisri P, et al. Rapid diagnosis of cholera caused by Vibrio cholerae O139. J Clin Microbiol 1998; 36:3595-3600.
65. Hasan JAK, Huq A, Nair GB, Garg S, Mukhopadhyay AK, Loomis L, et al. Development and testing of monoclonal antibody-based rapid immunodiagnostic test kits for direct detection of Vibrio cholerae O139 synonym Bengal. J Clin Microbiol 1995; 33:2935-2939.
66. Qadri F, Hasan JAK, Hossain J, Chowdhury A, Begum YA, Azim T, et al. Evaluation of the monoclonal antibody based kit. Bengal SMART for rapid detection of Vibrio cholerae O139 synonym Bengal in stool samples. J Clin Microbiol 1995; 33:732-734.
67. Nato F, Boutonnier A, Rajerison M, Grosjean P, Dartevelle S, Guenole A, et al. One-step immunochromatographic dipstick tests for rapid detection of Vibrio cholerae O1 and O139 in stool samples. Clin Diagn Lab Immunol 2003; 10:476-478.
68. Bhuiyan NA, Qadri F, Faruque ASG, Malek MA, Salam MA, Nato F, et al. Use of dipsticks for rapid diagnosis of cholera caused by Vibrio cholerae O1 and O139 from rectal swabs. J Clin Microbiol 2003; 41:3939-3941.
69. Nair GB, Bag PK, Shimada T, Ramamurthy T, Takeda T, Yamamoto S, et al. Evaluation of DNA probes for specific detection of Vibrio cholerae O139 Bengal. J Clin Microbiol 1995; 33:2186-2187.
70. Waldor MK, Tschape H, Mekalanos JJ. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J Bacteriol 1996; 178:4157-4165.
71. Yamamoto T, Nair GB, Albert MJ, Parodi CC, Takeda Y. Survey of in vitro susceptibility of Vibrio cholerae O1 and O139 to antimicrobial agents. Antimicrob Agents Chemother 1995; 39:241-244.
72. Mukhopadhyay SK, Basu A, Garg P, Bag PK, Ghosh A, Bhattacharya SK, et al. Molecular epidemiology of re-emergent Vibrio cholerae O139 Bengal in India. J Clin Microbiol 1998; 36:2149-2152.
73. Hochhut B, Lotfi Y, Mazel D, Faruque SM, Woodgate R, Waldor MK. Molecular analysis of antibiotic resistance gene cluster in Vibrio cholerae O139 and O1 SXT constins. Anitmicrob Agents Chemother 2001; 45:2991-3000.
74. Garg P, Chakraborty S, Basu I, Datta S, Rajendran K, Bhattacharya T, et al. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect 2000; 124:393-399.
75. Johnson JA, Joseph A, Morris JG Jr. Capsular polysaccharide protein conjugate vaccines against Vibrio cholerae O139 Bengal. Bull Inst Pasteur 1995; 93:285-290.
76. Kossaczka Z, Szu SC. Evaluation of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin. Glycoconj J 2000; 17:425-433.
77. Kossaczka Z, Shiloach J, Johnson V, Taylor DN, Finkelstein RA, Robbins JB, et al. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice. Infect Immun 2000; 68:5037-5043.
78. Boutonnier A, Villeneuve S, Nato F, Dassy B, Fournier JM. Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid. Infect Immun 2001; 69:3488-3493.
79. Jertborn M, Svennerholm A-M, Holmgren J. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine. Vaccine 1996; 14:1459-1465.
80. Trach DD, Cam PD, Ke NT, Rao MR, Dinh D, Hang PV, et al. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Vietnam. Bull WHO 2002; 80:2-8.
81. Khiem HB, Huan le D, Phuong NT, Dang DH, Hoang do H, Phuong le T, et al. Mass psychogenic illness following oral cholera immunization in Ca Mau city, Vietnam. Vaccine 2003; 21:4527-4531.
82. Tacket CO, Losonsky G, Nataro JP, Comstock L, Mickalski J, Edelman R, et al. Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J Infect Dis 1995; 172:883-886.
83. Coster TS, Killeen KP, Waldor MK, Beattie DT, Spriggs DR, Kenner JR, et al. Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet 1995; 345:949-952.
84. Favre D, Cryz SJ Jr, Viret JF. Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139. Infect Immun 1996; 64:3565-3570.
85. Nair GB, Ramamurthy T, Bhattacharya SK, Mukhopadhyay AK, Garg S, Bhattacharya MK, et al. Spread of Vibrio cholerae O139 Bengal in India. J Infect Dis 1994; 169:1029-1034.
86. Siddique AK, Akram K, Zaman K, Mutsuddy P, Eusof A, Sack RB. Vibrio cholerae O139: How great is the threat of a pandemic? Trop Med Intl Health 1996; 1:393-398.
87. Sharma C, Nair GB, Mukhopadhyay AK, Bhattacharya SK, Ghosh RK, Ghosh A. Molecular characterization of Vibrio cholerae O1 biotype El Tor strains isolated between 1992 and 1995 in Calcutta, India: evidence for the emergence of a new clone of the El Tor biotype. J Infect Dis 1997; 175:1134-1141.
88. Mitra R, Basu A, Dutta D, Nair GB, Takeda Y. Resurgence of Vibrio cholerae O139 Bengal with altered antibiogram in Calcutta, India. Lancet 1996; 348:1181.
89. Raut S, Jalgaonkar SV, Tankhiwale NS, Agarwal VA. Re-emergence of Vibrio cholerae O139 serogroup during 1998 in Nagpur (Maharashtra), India. Indian J Med Res 1999; 109:1-2.
90. Kaur H, Lal M. Reapperance of Vibrio cholerae O139 during March-August, 1998 in Ludhiana (Punjab), India. Indian J Med Res 1999; 109:3-4.
91. Faruque SM, Siddique AK, Saha MN, Asadulghani, Rahman MM, Zaman K, et al. Molecular characterization of a new ribotype of Vibrio cholerae O139 Bengal associated with an outbreak of cholera in Bangladesh. J Clin Microbiol 1999, 37:1313-1318.
92. Faruque SM, Chowdhury N, Kamruzzaman M, Ahmad QS, Faruque ASG, Salam MA, et al. Reemergence of epidemic Vibrio cholerae O139, Bangladesh. Emerg Infect Dis 2003; 9:1116-1122.
93. Sack RB, Siddique AK, Longini IM Jr, Nizam A, Yunus M, Islam MS, et al. A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. J Infect Dis 2003; 187:96-101.
94. Kam KM, Luey CKY, Tsang YM, Law CP, Chu MY, Cheung TL, et al. Molecular subtyping of Vibrio cholerae O1 and O139 by puised-field gel electrophoresis in Hong Kong: correlation with epidemiological events from 1994 to 2002. J Clin Microbiol 2003; 41:4502-4511.
95. Lin C-H, Wang T-K, Lee C-L, Pan T-M, Tsai J-L, Ho S-I, et al. Molecular epidemiology of newly emerged V. cholerae O139 in Taiwan. J Food Drug Analysis 2001; 9:224-231.
96. Eroshenko GA, Osin AV, Shchelkanova E, Smirnova NI. A comparative analysis of genomes of virulent and avirulent strains of Vibrio cholerae O139. Mol Gen Mikrobiol Virusol 2004; 2:11-16.